Alzamend Neuro, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $2.0M | $1.9M |
| FY2022 | — | $13.4M | $14.1M |
| FY2023 | — | $3.0M | $5.1M |
| FY2024 | — | $-2.6M | $376.0K |
| FY2025 | — | $4.0M | $3.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $2.0M | $1.9M |
| FY2022 | — | $13.4M | $14.1M |
| FY2023 | — | $3.0M | $5.1M |
| FY2024 | — | $-2.6M | $376.0K |
| FY2025 | — | $4.0M | $3.9M |